LU92048I2 - Tocilizumab - Google Patents

Tocilizumab

Info

Publication number: LU92048I2
Authority: LU; Luxembourg
Prior art keywords: cell growth; growth inhibitor; synovial cell; antibody; treatment
Prior art date: 1994-10-07

Application number

LU92048C

Other languages

English (en)

Original Assignee

Chugai Pharmaceutical Co Ltd

Kishimoto Tadamitsu

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-07

Filing date

2012-07-20

Publication date

2012-09-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17112746&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU92048(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-07-20 Application filed by Chugai Pharmaceutical Co Ltd, Kishimoto Tadamitsu filed Critical Chugai Pharmaceutical Co Ltd

2012-09-20 Publication of LU92048I2 publication Critical patent/LU92048I2/fr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/248—IL-6
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Orthopedic Medicine & Surgery (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Steroid Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

LU92048C 1994-10-07 2012-07-20 Tocilizumab LU92048I2 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP24403594		1994-10-07
PCT/JP1995/001144 WO1996011020A1 (fr)	1994-10-07	1995-06-07	Medicament contre la polyarthrite rhumatoide contenant un antagoniste d'interleukine 6 comme principe actif

Publications (1)

Publication Number	Publication Date
LU92048I2 true LU92048I2 (fr)	2012-09-20

Family

ID=17112746

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU92048C LU92048I2 (fr)	1994-10-07	2012-07-20	Tocilizumab

Country Status (18)

Country	Link
EP (3)	EP0783893B1 (fr)
JP (1)	JP3067987B2 (fr)
KR (1)	KR100306517B1 (fr)
CN (2)	CN101601861A (fr)
AT (1)	ATE552012T1 (fr)
AU (1)	AU700819B2 (fr)
CA (1)	CA2201781C (fr)
CZ (1)	CZ296919B6 (fr)
DK (1)	DK0783893T3 (fr)
ES (1)	ES2384222T3 (fr)
FI (1)	FI120721B (fr)
HU (1)	HU223602B1 (fr)
LU (1)	LU92048I2 (fr)
NO (4)	NO321089B1 (fr)
PL (1)	PL186506B1 (fr)
PT (1)	PT783893E (fr)
RU (1)	RU2147443C1 (fr)
WO (1)	WO1996011020A1 (fr)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU736282B2 (en) *	1997-03-21	2001-07-26	Chugai Seiyaku Kabushiki Kaisha	A preventive or therapeutic agent for sensitized T cell- mediated diseases comprising IL-6 antagonist as an active ingredient
KR20040024561A (ko) *	1997-08-15	2004-03-20	츄가이 세이야꾸 가부시키가이샤	항 인터루킨-6 수용체 항체를 유효성분으로서 함유하는전신성 홍반성 낭창의 예방 및/또는 치료제
ATE383875T1 (de)	1998-03-17	2008-02-15	Chugai Pharmaceutical Co Ltd	Prophylaktische oder therapeutische mittel gegen entzündliche erkrankungen des verdauungstraktes enthaltend antagonistische il-6 rezeptor antikörper
WO1999054478A1 (fr)	1998-04-17	1999-10-28	Suntory Limited	Gene codant pour une proteine douee d'une activite de synthese d'aurone
AU1095202A (en) *	2000-10-25	2002-05-06	Chugai Pharmaceutical Co Ltd	Preventives or remedies for psoriasis containing as the active ingredient il-6 antagonist
US20050074434A1 (en) *	2001-02-23	2005-04-07	Tomoaki Hoshino	Remedies for metabolic bone diseases
UA80091C2 (en) *	2001-04-02	2007-08-27	Chugai Pharmaceutical Co Ltd	Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
PL366469A1 (en) *	2001-04-05	2005-02-07	Immuno-Biological Laboratories Co, Ltd.	Anti-osteopontin antibody and use thereof
WO2003068260A1 (fr)	2002-02-14	2003-08-21	Chugai Seiyaku Kabushiki Kaisha	Produits pharmaceutiques en solution contenant des anticorps
GB2401040A (en)	2003-04-28	2004-11-03	Chugai Pharmaceutical Co Ltd	Method for treating interleukin-6 related diseases
JP2007104901A (ja) *	2004-01-16	2007-04-26	Astellas Pharma Inc	関節リウマチ治療薬のスクリーニング法
CA2555688C (fr) *	2004-02-11	2011-11-08	Warner-Lambert Company Llc	Methodes de traitement de l'osteoarthrose avec des antagonistes de l'interleukine-6
AR048335A1 (es)	2004-03-24	2006-04-19	Chugai Pharmaceutical Co Ltd	Agentes terapeuticos para trastornos del oido interno que contienen un antagonista de il- 6 como un ingrediente activo
RU2293559C2 (ru) *	2005-03-09	2007-02-20	Лидия Николаевна Долгова	Способ подготовки к любрикантной терапии
RU2293560C2 (ru) *	2005-03-09	2007-02-20	Лидия Николаевна Долгова	Способ лечения хронических гонартритов у больных остеоартрозом
KR101374454B1 (ko)	2005-03-31	2014-03-17	추가이 세이야쿠 가부시키가이샤	회합제어에 의한 폴리펩티드 제조방법
PA8672101A1 (es) *	2005-04-29	2006-12-07	Centocor Inc	Anticuerpos anti-il-6, composiciones, métodos y usos
BRPI0616446A2 (pt) *	2005-09-28	2011-06-21	Cytos Biotechnology Ag	composição contendo conjugados de interleucina-1, vacina, uso da vacina, composição farmacêutica, processo para a produção da composição ou da vacina, bem como medicamento
US8470316B2 (en)	2005-10-14	2013-06-25	Chugai Seiyaku Kabushiki Kaisha	Agents for suppressing damage to transplanted islets after islet transplantation
RU2450830C2 (ru)	2005-10-21	2012-05-20	Чугаи Сейяку Кабусики Кайся	Средства для лечения кардиопатии
AR057582A1 (es)	2005-11-15	2007-12-05	Nat Hospital Organization	Agentes para suprimir la induccion de linfocitos t citotoxicos
JP5033643B2 (ja)	2006-01-27	2012-09-26	学校法人慶應義塾	脈絡膜血管新生を伴う疾患の治療剤
EP4793360A2 (fr)	2006-03-31	2026-08-19	Chugai Seiyaku Kabushiki Kaisha	Procédés de régulation de la pharmacocinétique sanguine d'anticorps
JP5144499B2 (ja)	2006-03-31	2013-02-13	中外製薬株式会社	二重特異性抗体を精製するための抗体改変方法
JP5754875B2 (ja)	2006-04-07	2015-07-29	国立大学法人大阪大学	筋再生促進剤
US8080248B2 (en)	2006-06-02	2011-12-20	Regeneron Pharmaceuticals, Inc.	Method of treating rheumatoid arthritis with an IL-6R antibody
ATE537190T1 (de)	2006-06-02	2011-12-15	Regeneron Pharma	Hochaffine antikörper gegen den humanen il-6- rezeptor
WO2008019061A2 (fr)	2006-08-03	2008-02-14	Vaccinex, Inc.	Anticorps monoclonaux anti-il-6 et leurs utilisations
JP2010095445A (ja) *	2006-12-27	2010-04-30	Tokyo Medical & Dental Univ	Ｉｌ−６アンタゴニストを有効成分とする炎症性筋疾患治療剤
MX2009007830A (es)	2007-01-23	2009-10-07	Univ Shinshu	Inhibidor de rechazo cronico.
ES2687808T3 (es)	2007-09-26	2018-10-29	Chugai Seiyaku Kabushiki Kaisha	Región constante de anticuerpo modificado
RU2505603C2 (ru)	2007-09-26	2014-01-27	Чугаи Сейяку Кабусики Кайся	Антитело против рецептора il-6
EP3127921A1 (fr)	2007-09-26	2017-02-08	Chugai Seiyaku Kabushiki Kaisha	Procédé de modification d'un anticorps par point isoélectrique par substitution d'acide aminé dans cdr
TWI548418B (zh)	2007-12-05	2016-09-11	中外製藥股份有限公司	Anti-NR10 / IL-31RA antibody and its use
TW201920257A (zh)	2008-04-11	2019-06-01	日商中外製藥股份有限公司	重複結合複數個抗原的抗原結合分子
JP2011520898A (ja)	2008-05-13	2011-07-21	ノビミューンエスアー	抗ｉｌ−６／ｉｌ−６ｒ抗体およびそれらの使用方法
TW201503898A (zh) *	2008-06-05	2015-02-01	Chugai Pharmaceutical Co Ltd	神經浸潤抑制劑
US8188235B2 (en)	2008-06-18	2012-05-29	Pfizer Inc.	Antibodies to IL-6 and their uses
TWI440469B (zh)	2008-09-26	2014-06-11	Chugai Pharmaceutical Co Ltd	Improved antibody molecules
TWI544077B (zh)	2009-03-19	2016-08-01	中外製藥股份有限公司	Antibody constant region change body
JP5717624B2 (ja)	2009-03-19	2015-05-13	中外製薬株式会社	抗体定常領域改変体
CN102459344A (zh)	2009-05-15	2012-05-16	中外制药株式会社	抗axl抗体
CN102427822A (zh) *	2009-05-18	2012-04-25	香港大学	治疗炎症性关节炎的组合物和方法
US10150808B2 (en)	2009-09-24	2018-12-11	Chugai Seiyaku Kabushiki Kaisha	Modified antibody constant regions
JO3417B1 (ar)	2010-01-08	2019-10-20	Regeneron Pharma	الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r
AR080428A1 (es)	2010-01-20	2012-04-11	Chugai Pharmaceutical Co Ltd	Formulaciones liquidas estabilizadas contentivas de anticuerpos
EP2543730B1 (fr)	2010-03-04	2018-10-31	Chugai Seiyaku Kabushiki Kaisha	Variante de région constante d'anticorps
RS63800B1 (sr)	2010-05-28	2022-12-30	Chugai Pharmaceutical Co Ltd	Poboljšanje antitumorskog odgovora t ćelije
JP5904552B2 (ja)	2010-05-28	2016-04-13	国立研究開発法人国立がん研究センター	膵癌治療剤
KR101933197B1 (ko)	2010-11-08	2018-12-27	제넨테크, 인크.	피하 투여용 항―ｉｌ―6 수용체 항체
CN105859889B (zh)	2010-11-17	2020-01-07	中外制药株式会社	具有代替凝血因子viii的功能的功能的多特异性抗原结合分子
TWI654203B (zh)	2010-11-30	2019-03-21	Chugai Seiyaku Kabushiki Kaisha	具有鈣依存性的抗原結合能力之抗體
JP4987117B2 (ja)	2010-12-27	2012-07-25	中外製薬株式会社	Ｉｌ−６アンタゴニストを有効成分として含有する血中ｍｍｐ−３濃度低下剤
SG10201609665PA (en)	2011-02-25	2017-01-27	Chugai Pharmaceutical Co Ltd	FcɣRIIb-SPECIFIC Fc ANTIBODY
JP6322411B2 (ja)	2011-09-30	2018-05-09	中外製薬株式会社	複数の生理活性を有する抗原の消失を促進する抗原結合分子
TW201817745A (zh)	2011-09-30	2018-05-16	日商中外製藥股份有限公司	具有促進抗原清除之ＦｃＲｎ結合域的治療性抗原結合分子
TWI589299B (zh)	2011-10-11	2017-07-01	再生元醫藥公司	用於治療類風濕性關節炎之組成物及其使用方法
WO2013087914A1 (fr)	2011-12-16	2013-06-20	Synthon Biopharmaceuticals B.V.	Expression d'anticorps iga sécrétoires chez la lentille d'eau
JP6117915B2 (ja)	2012-05-21	2017-04-19	コリアリサーチインスティテュートオブバイオサイエンスアンドバイオテクノロジーＫｏｒｅａＲｅｓｅａｒｃｈＩｎｓｔｉｔｕｔｅＯｆＢｉｏｓｃｉｅｎｃｅＡｎｄＢｉｏｔｅｃｈｎｏｌｏｇｙ	ミゾコウジュの抽出物またはその分画物を有効成分として含む、ｓｔａｔ３媒介性疾患の予防または治療用医薬組成物
EP3009518B1 (fr)	2013-06-11	2020-08-12	National Center of Neurology and Psychiatry	Procédé permettant de prédire le pronostic post-thérapie d'un patient atteint de sclérose en plaques à périodes progressives et rémittentes (spppr) et procédé permettant de déterminer l'applicabilité d'une nouvelle thérapie
CA2925256C (fr)	2013-09-27	2023-08-15	Chugai Seiyaku Kabushiki Kaisha	Procede de production d'un heteromultimere polypeptidique
US9017678B1 (en)	2014-07-15	2015-04-28	Kymab Limited	Method of treating rheumatoid arthritis using antibody to IL6R
MA40764A (fr)	2014-09-26	2017-08-01	Chugai Pharmaceutical Co Ltd	Agent thérapeutique induisant une cytotoxicité
EA201791366A1 (ru)	2014-12-19	2018-02-28	Чугаи Сейяку Кабусики Кайся	Антитела к c5 и способы их применения
MX2017005774A (es)	2014-12-19	2017-07-28	Chugai Pharmaceutical Co Ltd	Anticuerpos antimiostatina, polipeptidos que contienen regiones fc variantes, y metodos de uso.
CN114773469B (zh)	2015-02-05	2025-12-19	中外制药株式会社	包含离子浓度依赖性的抗原结合结构域的抗体，fc区变体，il-8-结合抗体及其应用
TWI759261B (zh)	2015-02-27	2022-04-01	日商中外製藥股份有限公司	Ｉｌ－６受體抗體用於製備醫藥組成物的用途
JP7082484B2 (ja)	2015-04-01	2022-06-08	中外製薬株式会社	ポリペプチド異種多量体の製造方法
JP6875683B2 (ja)	2015-05-19	2021-05-26	国立研究開発法人国立精神・神経医療研究センター	多発性硬化症（ｍｓ）患者の新規治療適用判断方法
JP7128460B2 (ja)	2015-06-04	2022-08-31	国立研究開発法人国立精神・神経医療研究センター	Ｉｌ－６阻害剤を有効成分とする精神疾患治療剤
BR112018008900A8 (pt)	2015-11-03	2019-02-26	Regeneron Pharma	composições compreendendo anticorpos para il6r para o tratamento de uveíte e edema macular e métodos de uso das mesmas
EP3394098A4 (fr)	2015-12-25	2019-11-13	Chugai Seiyaku Kabushiki Kaisha	Anticorps anti-myostatine et procédés d'utilisation
SG11201803989WA (en)	2015-12-28	2018-06-28	Chugai Pharmaceutical Co Ltd	Method for promoting efficiency of purification of fc region-containing polypeptide
EP3431102A4 (fr)	2016-03-14	2019-09-25	Chugai Seiyaku Kabushiki Kaisha	Médicament thérapeutique induisant des lésions cellulaires à utiliser dans le traitement du cancer
AU2017255077B2 (en)	2016-04-28	2024-05-16	Chugai Seiyaku Kabushiki Kaisha	Antibody-containing preparation
CN116271014A (zh)	2016-08-05	2023-06-23	中外制药株式会社	用于预防或治疗il-8相关疾病的组合物
CN108339118A (zh) *	2017-01-23	2018-07-31	瑞阳(苏州)生物科技有限公司	治疗或预防阻塞性睡眠呼吸暂停的药物组合物
JP7209298B2 (ja)	2017-03-31	2023-01-20	公立大学法人奈良県立医科大学	血液凝固第ｖｉｉｉ因子の機能を代替する多重特異性抗原結合分子を含有する、血液凝固第ｉｘ因子異常症の予防および／または治療に用いられる医薬組成物
EP3620531A4 (fr)	2017-05-02	2021-03-17	National Center of Neurology and Psychiatry	Procédé de prédiction et d'évaluation d'un effet thérapeutique dans des maladies associées à il-6 et à des neutrophiles
CN111051343B (zh)	2017-09-13	2022-11-22	江苏恒瑞医药股份有限公司	Il-6r抗体、其抗原结合片段及医药用途
WO2019078344A1 (fr)	2017-10-20	2019-04-25	学校法人兵庫医科大学	Composition médicinale contenant un anticorps du recepteur anti-il -6 pour prévenir l'adhérence post-chirurgicale
KR20260090008A (ko)	2017-11-01	2026-06-16	추가이 세이야쿠 가부시키가이샤	생물 활성이 저하된 항체 배리언트 및 아이소폼
TWI822728B (zh)	2018-01-31	2023-11-21	加藤元一	含有il-6抑制劑的哮喘治療劑
KR20260109977A (ko)	2018-08-29	2026-07-13	리제너론 파아마슈티컬스, 인크.	류마티스성 관절염을 갖는 대상체를 치료하기 위한 방법 및 조성물
CN109517064B (zh) *	2018-10-10	2020-05-08	北京汇智和源生物技术有限公司	白介素-6的人源化单克隆抗体、其编码基因及应用
JP7542543B2 (ja)	2019-01-31	2024-08-30	サノフィ・バイオテクノロジー	若年性特発性関節炎を治療するための抗ｉｌ－６受容体抗体
WO2020178193A1 (fr)	2019-03-01	2020-09-10	INSERM (Institut National de la Santé et de la Recherche Médicale)	Méthode de traitement de la sarcoïdose
AU2020259884A1 (en)	2019-04-17	2021-10-07	Chugai Seiyaku Kabushiki Kaisha	Therapeutic agent for urological cancer which is characterized by being administered with il-6 inhibitor and ccr2 inhibitor in combination
JP2022545312A (ja)	2019-04-24	2022-10-27	サノフィ・バイオテクノロジー	関節リウマチの診断及び処置の方法
CA3142710A1 (fr)	2019-06-04	2020-12-10	Sanofi Biotechnology	Compositions et procedes de traitement de la douleur chez des sujets atteints de polyarthrite rhumatoide
US12558423B2 (en)	2020-05-29	2026-02-24	Chugai Seiyaku Kabushiki Kaisha	Antibody-containing formulation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5171840A (en)	1988-01-22	1992-12-15	Tadamitsu Kishimoto	Receptor protein for human B cell stimulatory factor-2
EP0399429A1 (fr) *	1989-05-22	1990-11-28	Toray Industries, Inc.	Anticorps monoclonal contre l'interleukine-6 humaine
SG42954A1 (en) *	1989-07-20	1997-10-17	Tadamitsu Kishimoto	Antibody to human interleukin-6 receptor
JP2898064B2 (ja)	1989-08-03	1999-05-31	忠三岸本	ヒトｇｐ１３０蛋白質
DE3939706C1 (fr) *	1989-12-01	1991-03-21	Centre Regional De Transfusion Sanguine, Besancon, Fr
JPH0747547B2 (ja) *	1989-12-04	1995-05-24	シェリング・コーポレーション	敗血症性ショック治療用医薬組成物
JP2898040B2 (ja)	1990-01-26	1999-05-31	忠三岸本	ｇｐ１３０蛋白質に対する抗体
US5210075A (en) *	1990-02-16	1993-05-11	Tanabe Seiyaku Co., Ltd.	Interleukin 6 antagonist peptides
JPH0489433A (ja)	1990-07-27	1992-03-23	Hitachi Chem Co Ltd	免疫調節剤
JP2947924B2 (ja) *	1990-11-21	1999-09-13	信和化工株式会社	光学異性体用分離剤
JPH04187645A (ja) *	1990-11-22	1992-07-06	Chuzo Kishimoto	インターロイキン―６作用抑制剤
AU668349B2 (en)	1991-04-25	1996-05-02	Chugai Seiyaku Kabushiki Kaisha	Reconstituted human antibody against human interleukin 6 receptor
JPH05300338A (ja)	1992-04-17	1993-11-12	Ricoh Co Ltd	複合機
JPH05304986A (ja) *	1992-04-28	1993-11-19	Tosoh Corp	ｇｐ１３０蛋白質に対するモノクロ−ナル抗体
FR2694767B1 (fr) *	1992-08-13	1994-10-21	Innotherapie Lab Sa	Anticorps monoclonaux anti-IL6R, et leurs applications.
JPH06134617A (ja)	1992-10-23	1994-05-17	Amada Co Ltd	鋸盤の鋸刃テンション自動調整装置
JP3525221B2 (ja) *	1993-02-17	2004-05-10	味の素株式会社	免疫抑制剤

1995
- 1995-06-07 AU AU26303/95A patent/AU700819B2/en not_active Expired
- 1995-06-07 EP EP95921130A patent/EP0783893B1/fr not_active Expired - Lifetime
- 1995-06-07 PT PT95921130T patent/PT783893E/pt unknown
- 1995-06-07 KR KR1019970702209A patent/KR100306517B1/ko not_active Expired - Lifetime
- 1995-06-07 CA CA002201781A patent/CA2201781C/fr not_active Expired - Lifetime
- 1995-06-07 RU RU97108276A patent/RU2147443C1/ru active Protection Beyond IP Right Term
- 1995-06-07 EP EP09009350A patent/EP2107070A1/fr not_active Withdrawn
- 1995-06-07 DK DK95921130.1T patent/DK0783893T3/da active
- 1995-06-07 AT AT95921130T patent/ATE552012T1/de active
- 1995-06-07 CN CNA2009101322726A patent/CN101601861A/zh active Pending
- 1995-06-07 ES ES95921130T patent/ES2384222T3/es not_active Expired - Lifetime
- 1995-06-07 HU HU9701906A patent/HU223602B1/hu active Protection Beyond IP Right Term
- 1995-06-07 WO PCT/JP1995/001144 patent/WO1996011020A1/fr not_active Ceased
- 1995-06-07 CN CN2008102100070A patent/CN101361972B/zh not_active Expired - Lifetime
- 1995-06-07 PL PL95319574A patent/PL186506B1/pl unknown
- 1995-06-07 CZ CZ0103497A patent/CZ296919B6/cs not_active IP Right Cessation
- 1995-06-07 EP EP09000787A patent/EP2077120A3/fr not_active Withdrawn
- 1995-10-06 JP JP7284364A patent/JP3067987B2/ja not_active Expired - Lifetime
1997
- 1997-04-04 FI FI971404A patent/FI120721B/fi not_active IP Right Cessation
- 1997-04-04 NO NO19971546A patent/NO321089B1/no not_active IP Right Cessation
2005
- 2005-11-17 NO NO20055446A patent/NO20055446L/no not_active Application Discontinuation
2009
- 2009-05-04 NO NO2009009C patent/NO2009009I2/no unknown
2012
- 2012-07-20 LU LU92048C patent/LU92048I2/fr unknown
2018
- 2018-05-23 NO NO2018017C patent/NO2018017I1/no unknown

Also Published As

Publication number	Publication date
NO2009009I2 (no)	2013-03-18
ATE552012T1 (de)	2012-04-15
NO20055446L (no)	1997-06-04
ES2384222T3 (es)	2012-07-02
NO2009009I1 (no)	2009-05-11
CA2201781C (fr)	2010-01-12
EP0783893B1 (fr)	2012-04-04
FI120721B (fi)	2010-02-15
HU223602B1 (hu)	2004-10-28
RU2147443C1 (ru)	2000-04-20
CN101601861A (zh)	2009-12-16
DK0783893T3 (da)	2012-05-29
AU700819B2 (en)	1999-01-14
KR100306517B1 (ko)	2001-11-30
EP0783893A1 (fr)	1997-07-16
AU2630395A (en)	1996-05-02
EP2077120A3 (fr)	2009-07-15
CA2201781A1 (fr)	1996-04-18
FI971404A0 (fi)	1997-04-04
PL186506B1 (pl)	2004-01-30
WO1996011020A1 (fr)	1996-04-18
EP2077120A2 (fr)	2009-07-08
EP0783893A4 (fr)	1998-04-22
HUT77036A (hu)	1998-03-02
NO321089B1 (no)	2006-03-13
HK1127497A1 (en)	2009-09-25
JP3067987B2 (ja)	2000-07-24
PT783893E (pt)	2012-05-24
CN101361972A (zh)	2009-02-11
CN101361972B (zh)	2011-05-25
JPH08208514A (ja)	1996-08-13
PL319574A1 (en)	1997-08-18
FI971404L (fi)	1997-06-03
NO2018017I1 (no)	2018-05-23
NO971546D0 (no)	1997-04-04
CZ103497A3 (en)	1997-08-13
CZ296919B6 (cs)	2006-07-12
NO971546L (no)	1997-06-04
EP2107070A1 (fr)	2009-10-07

Publication	Publication Date	Title
NO2009009I2 (no)	2013-03-18	Tocilizumab
RU97108276A (ru)	1999-05-20	Лечебные средства против хронического ревматоидного артрита, содержащие антагонист il-6 в качестве эффективного компонента
DK0601386T3 (da)	2003-05-26	Sulfonamider
NL1002835A1 (nl)	1996-10-14	Synergistisch stabilisatormengsel.
ES2172657T3 (es)	2002-10-01	Inhibidores de trombina.
ATE225772T1 (de)	2002-10-15	Thrombin-inhibitoren
IT1213574B (it)	1989-12-20	Inibitori ureidici di renina utili quali agenti ipertensivi.
EA200300834A1 (ru)	2004-02-26	Антагонисты фактора, высвобождающего кортикотропин
GR1000130B (el)	1991-07-31	Διαταξη για την επεξεργασια σπορων.
TR199801255T2 (xx)	1998-10-21	Vitronektin resept�r antagonistleri.
DK0839126T3 (da)	2001-08-06	Fremgangsmåde til fremstilling af organiske nitrogenforbindelser, specielle organiske nitrogenforbindelser og blandinger af sådanne forbindelser samt deres anvendelse som brændstof- og smøremiddeladditiver
EA200100688A1 (ru)	2001-12-24	АЗОТСОДЕРЖАЩИЕ ГЕТЕРОБИЦИКЛЫ В КАЧЕСТВЕ ИНГИБИТОРОВ ФАКТОРА Xa
DK0705100T3 (da)	2003-11-17	Terapeutiske substituerede guanidiner
IT8421491A0 (it)	1984-06-19	Battuta regolabile per un tavolo di sega o similare.
ES8801912A1 (es)	1987-08-01	Procedimiento para la obtencion de benzopiranos sustituidos.
ATE198202T1 (de)	2001-01-15	Fibrinogen receptor antagonisten
IT1231727B (it)	1991-12-21	Peptidi utili per la determinazione e la purificazione di anticorpi anti gamma interferone.
YU48915B (sh)	2002-11-15	Sulfonilkarbamid i postupak za njegovo dobijanje
DK0504307T3 (da)	1994-03-21	Fremgangsmåde til behandling af septisk shock
ITRM940126A0 (it)	1994-03-09	Additivo per composizioni cementizie. (caso 154-0241)
KR950700305A (ko)	1995-01-16	칼슘 통로 길항제로서 아자바이사이클로 화합물(Azabicyclo compounds as calcium channel antagonists)
FR2785842B1 (fr)	2001-02-02	Dispositif pour la fabrication automatisee de ceintures de caisses par agrafage ou par clouage
ATE53492T1 (de)	1990-06-15	Formulierung von entzuendungshemmenden arzneimitteln.
IT1229153B (it)	1991-07-22	Procedimento per la modificazione di emulsioni di bitume mediante elastomeri.
FR2663945B1 (fr)	1994-09-09	Liquide inhibiteur de combustion auto extinguible.